These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3479928)

  • 1. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation.
    Koski CL
    Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
    Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
    J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies to peripheral nerve antigens in Guillain-Barré syndrome.
    Negishi T; Yamashita T; Nomura K; Hosokawa T; Ohno R; Hamaguchi K; Uyemura K
    Ann N Y Acad Sci; 1988; 540():376-7. PubMed ID: 2462815
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
    Koski CL
    Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of antiglycolipid antibodies.
    Baumann N
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):31-40. PubMed ID: 11064824
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy.
    Caudie C
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):7-18. PubMed ID: 11064822
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between autoantibody specificities and peripheral nervous system involvements.
    Jauberteau-Marchan MO
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):41-9. PubMed ID: 11064825
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis.
    Vriesendorp FJ; Mayer RF; Koski CL
    Arch Neurol; 1991 Aug; 48(8):858-61. PubMed ID: 1898263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
    Koski CL; Chou DK; Jungalwala FB
    J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain-Barré syndrome. Preliminary communication.
    Luijten JA; Baart de la Faille-Kuyp
    J Neurol Sci; 1972 Feb; 15(2):219-24. PubMed ID: 4334504
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange.
    Osterman PO; Vedeler CA; Ryberg B; Fagius J; Nyland H
    J Neurol; 1988 May; 235(5):285-9. PubMed ID: 3385444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome associated with idiopathic thrombocytopenic purpura.
    Combarros O; Calleja J; Hernández L; Polo JM; Berciano J
    J Neurol Neurosurg Psychiatry; 1991 Jul; 54(7):654-5. PubMed ID: 1895135
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies.
    Vedeler CA; Nyland H
    Acta Neurol Scand; 1990 Aug; 82(2):147-9. PubMed ID: 2256446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing.
    Lunn MP; Crawford TO; Hughes RA; Griffin JW; Sheikh KA
    Brain; 2002 Apr; 125(Pt 4):904-11. PubMed ID: 11912122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
    Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
    J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.
    Sanders ME; Alexander EL; Koski CL; Shin ML; Sano Y; Frank MM; Joiner KA
    Ann N Y Acad Sci; 1988; 540():387-8. PubMed ID: 3207265
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraneoplastic autoimmunity.
    Steck AJ; Nardelli E
    Ann N Y Acad Sci; 1988; 540():91-8. PubMed ID: 2462848
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial polyneuropathy with anti-myelin-associated glycoprotein antibodies.
    Srinivasan J; Tseng VG; Yang D; Harris BT; Jones HR; Stommel EW
    Neurology; 2005 Jun; 64(11):1983-4. PubMed ID: 15955965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.